| __timestamp | Axsome Therapeutics, Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1392830 | 2652041 |
| Thursday, January 1, 2015 | 2419289 | 2361587 |
| Friday, January 1, 2016 | 6343648 | 4472869 |
| Sunday, January 1, 2017 | 7206691 | 5030957 |
| Monday, January 1, 2018 | 9351522 | 4988941 |
| Tuesday, January 1, 2019 | 13598030 | 5196412 |
| Wednesday, January 1, 2020 | 28896749 | 6652774 |
| Friday, January 1, 2021 | 66646205 | 18418247 |
| Saturday, January 1, 2022 | 159253661 | 24827066 |
| Sunday, January 1, 2023 | 323123000 | 41896408 |
| Monday, January 1, 2024 | 411359000 | 15488619 |
In pursuit of knowledge
In the competitive landscape of biotechnology, understanding a company's operational efficiency is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and Axsome Therapeutics, Inc. from 2014 to 2023. Over this period, Axsome's SG&A expenses surged by an astounding 23,000%, peaking in 2023, while Opthea's expenses grew by approximately 1,500%. This stark contrast highlights Axsome's aggressive expansion strategy compared to Opthea's more conservative approach. Notably, Axsome's expenses in 2023 were nearly eight times higher than Opthea's, reflecting its significant investment in growth and market penetration. However, the data for 2024 is incomplete, leaving room for speculation on future trends. Investors and analysts should consider these insights when evaluating the financial health and strategic direction of these companies.
Selling, General, and Administrative Costs: Johnson & Johnson vs Opthea Limited
Breaking Down SG&A Expenses: Amgen Inc. vs Opthea Limited
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Opthea Limited
Vertex Pharmaceuticals Incorporated or Axsome Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Insmed Incorporated vs Axsome Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Opthea Limited
Halozyme Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Opthea Limited or Verona Pharma plc
Opthea Limited and Vericel Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Opthea Limited and Amicus Therapeutics, Inc.
Opthea Limited or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Axsome Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared